Piper Sandler Reiterates Overweight Rating on Pacira Pharmaceuticals (PCRX)
Go back to Piper Sandler Reiterates Overweight Rating on Pacira Pharmaceuticals (PCRX)| PACIRA (NASDAQ: PCRX) | Delayed: 26.13 -0.28 (1.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.41 | 52 Week High | $80.25 | |||
| Open | $26.09 | 52 Week Low | $30.25 | |||
| Day High | $26.68 | P/E | N/A | |||
| Day Low | $25.92 | EPS | $-2.08 | |||
| Volume | 519,092 | |||||

